Phoscan Chemical Cp (PCCLF) 0.1560 $PCCLF Wingren B.V.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Phoscan Chemical Cp (PCCLF) 0.1560 $PCCLF

Wingren B.V. Files Early Warning Report
Marketwired - Tue Feb 02, 4:19PM CST
On February 2, 2016, Wingren B.V. ("NGP", c/o Prins Bernhardplein, 200, 1097 JB Amsterdam, The Netherlands, acquired ownership of 12,040,340 common shares ("New Petrus Shares" of Petrus Resources Ltd. (formerly known as Petrus Acquisition Corp.) ("New Petrus" pursuant to: (i) a plan of arrangement under section 193 of the Business Corporations Act (Alberta) (the "Arrangement" in accordance with the provisions of an arrangement agreement dated as of November 29, 2015, among Petrus Resources Corp. (formerly known as Petrus Resources Ltd.) ("Old Petrus", PhosCan Chemical Corp. ("PhosCan", New Petrus and Fox River Resources Corp.; and (ii) the completion of a private placement of subscription receipts to acquire New Petrus Shares ("New Petrus Subscription Receipts" upon completion of the Arrangement (the "Private Placement". NGP is owned, controlled or managed, directly or indirectly, by NGP Energy Capital Management.

Petrus Resources Announces Closing of Arrangement
Marketwired - Tue Feb 02, 4:09PM CST
Petrus Resources Ltd. ("Petrus" or the "Company" is pleased to announce that the previously announced plan of arrangement (the "Arrangement" involving Petrus, Petrus Resources Corp. ("Old Petrus", Petrus Resources Inc. (formerly PhosCan Chemical Corp.) ("PhosCan" and Fox River Resources Corporation ("Fox River" has closed, and aggregate gross proceeds from the previously announced $30 million bought deal financing (the "Financing" of subscription receipts of Petrus ("Subscription Receipts" have been released from escrow, resulting in aggregate gross proceeds to Petrus of approximately $75.4 million, inclusive of the gross proceeds of the Financing and the assumption of approximately $45.4 million of PhosCan's positive working capital.

PhosCan Granted Extension of TSX Delisting Review
Marketwired - Mon Nov 30, 4:22PM CST
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces that the Toronto Stock Exchange ("TSX" has notified the Company that TSX has decided to extend its review of the eligibility of the Company's common shares for continued listing for a period of 60 days.
FOS.TO: 0.22 (-0.01)

IIROC Trade Resumption - Phoscan Chemical Corp.
Newsfile Corp - Mon Nov 30, 8:58AM CST
Trading resumes in:

IIROC Trade Halt - Phoscan Chemical Corp.
Newsfile Corp - Mon Nov 30, 8:36AM CST
The following issues have been halted by IIROC:

PhosCan Chemical Announces Results for Quarter Ended October 31, 2015
Marketwired - Thu Nov 19, 4:39PM CST
PhosCan Chemical Corp. (TSX: FOS) today released its quarterly results for the period ended October 31, 2015.
FOS.TO: 0.22 (-0.01)

PhosCan Chemical Provides Corporate Update
Marketwired - Fri Oct 23, 3:45PM CDT
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces that the Board of Directors has decided not to accept the resignation of Mr. Gord McKinnon as a director of the Company. At the shareholders meeting held on July 28, 2015, Mr. McKinnon received fewer votes in favour of his re-election as a director than votes withheld. In accordance with the Company's Majority Voting Policy, Mr. McKinnon submitted his resignation to the Board, which resignation was subject to acceptance or rejection by the Board of Directors. Pursuant to the Policy, the Corporate Governance and Nominating Committee of the Company considered the resignation and made a recommendation to the Board. Both the Committee and the Board determined that, in light of Mr. McKinnon's involvement in the Company's ongoing strategic review process, it was not in the best interests of the Company or its shareholders for Mr. McKinnon to resign. Accordingly, the Board decided not to accept Mr. McKinnon's resignation, such that he will continue as a director of the Company. Mr. McKinnon did not participate in the consideration of his tendered resignation.
FOS.TO: 0.22 (-0.01)

PhosCan Chemical Announces Results for Quarter Ended July 31, 2015; Files Supplement to Information Circular
Marketwired - Fri Sep 11, 11:05AM CDT
(Expressed in Canadian Dollars)
FOS.TO: 0.22 (-0.01)

PhosCan Chemical Announces Results of Annual and Special Meeting
Marketwired - Wed Jul 29, 7:40AM CDT
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces the results of its annual and special meeting of shareholders (the "Meeting" held in Toronto, Ontario on July 28, 2015.
FOS.TO: 0.22 (-0.01)

PhosCan Provides Update on Strategic Review Process and Announces TSX Delisting Review
Marketwired - Thu Jul 23, 6:01AM CDT
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces that the Toronto Stock Exchange (the "TSX" has notified the Company that the TSX is reviewing the Company's eligibility for continued listing, based on the Company's level of active business operations. For the past few years the Company has limited its expenditures on the Martison phosphate project due to market conditions. The Company is being reviewed under the TSX' Remedial Review Process and has 120 days to comply with all requirements for continued listing. If the Company cannot demonstrate that it meets all TSX continued listing requirements on or before November 23, 2015, the Company's securities will be delisted 30 days from such date. If the Company is unable to satisfy TSX requirements, it will seek a listing on another Canadian stock exchange.
FOS.TO: 0.22 (-0.01)

PhosCan Chemical Announces Results for Quarter Ended April 30, 2015
Marketwired - Fri Jun 12, 1:57PM CDT
PhosCan Chemical Corp. (TSX: FOS) today released its quarterly results for the period ended April 30, 2015.
FOS.TO: 0.22 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Halozyme's Upcoming Investment Presentation at Healthcare Conference

Updated Category News Views 280

Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...

Continue Reading
Emerging Markets Surge Ahead with Historic Bond Sales Strategy

Updated Category News Views 241

Emerging Markets Adjust with Record Bond Sales Amid economic uncertainty, borrowers in developing regions are intensifying their efforts to navigate potential market turbulence, particularly due to significant fluctuations influenced by US economic conditions. Authorities and businesses have proactively begun securing funds through bond sales, reflecting a strategic move...

Continue Reading
Multi Ways Holdings Reflects on Fiscal Year 2024 Performance

Updated Category News Views 167

Multi Ways Holdings Limited Reports on Financial Results Multi Ways Holdings Limited (NYSE American: MWG), a prominent provider of heavy construction equipment, has recently shared its financial outcomes for the fiscal year 2024. With a focus on innovation and customer satisfaction in Singapore and neighboring regions, the company continues to adapt to the dynamic market...

Continue Reading
Neurocrine Adjusts Course Following Luvadaxistat Study Setback

Updated Category News Views 117

Neurocrine Biosciences Shifts Strategy After Luvadaxistat Trial Neurocrine Biosciences Inc. (NASDAQ: NBIX) has made revisions to its strategic approach following the outcomes of the ERUDITE phase two clinical trial involving luvadaxistat (NBI-1065844). This investigational treatment aimed at addressing cognitive impairment in schizophrenia did not achieve its primary...

Continue Reading
Rinnai America Leads Coalition Against DOE Water Heater Rule

Updated Category News Views 294

Rinnai America Takes Action Against DOE Regulations Rinnai America Corporation, a prominent manufacturer of noncondensing tankless water heaters, has joined forces with 21 state attorneys general and various business groups to challenge the recent final rule issued by the U.S. Department of Energy (DOE) concerning consumer tankless water heaters. This action follows a...

Continue Reading